W o r l d . C r y p t o . G l o b a l

Loading

Welcome at World Crypto Global. This portal is packed with useful content and resources to built out your own crypto skills. WorldCrypto is a site member of Gabriel Vega Network.

Contact Info

Get Free Coins
img
img

CATEGORY: otec

X complies with EU data laws, stops AI chatbot data collection
Author: Cointelegraph by Savannah Fortis
United States
Source: Cointelegraph.com News
Sep 07, 2024 12:00

X complies with EU data laws, stops AI chatbot data collection

X has resolved its legal battle with the European Data Protection Commission by agreeing to halt AI data collection practices and erase user data.

View Details View Details
Crypto PACs spend $14M targeting crucial US Senate and House races
Author: Cointelegraph by Turner Wright
United States
Source: Cointelegraph.com News
Sep 07, 2024 12:00

Crypto PACs spend $14M targeting crucial US Senate and House races

With most state primaries for the US House and Senate completed, the Fairshake PAC and its affiliates are supporting candidates in the November election.

View Details View Details
California passes bill to prohibit unauthorized AI replicas of the deceased
Author: Cointelegraph by Savannah Fortis
United States
Source: Cointelegraph.com News
Sep 05, 2024 12:00

California passes bill to prohibit unauthorized AI replicas of the deceased

Californias Senate passed Assembly Bill 1836, prohibiting unauthorized AI-generated replicas of deceased personalities without prior consent to protect performers rights and likenesses.

View Details View Details
Digital Health Stock Butterfly Network Inc. (NYSE: BFLY) Gains on Expansion News
United States
Source: Investorideas.com newswire, breaking stock market

Sep 05, 2024 07:00

Digital Health Stock Butterfly Network Inc. (NYSE: BFLY) Gains on Expansion News

September 4, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas, including biotech stocks and digital health stocks, reports on trading for Butterfly Network Inc. (NYSE: BFLY), a digital health company transforming care with portable semiconductor-based ultrasound technology and intuitive software.

View Details View Details
Telemedicine and Weight Loss Stocks to Watch
United States
Source: Investorideas.com newswire, breaking stock market

Sep 05, 2024 07:00

Telemedicine and Weight Loss Stocks to Watch

September 4, 2024 (Investorideas.com Newswire) Investorideas.com, a go-to investing platform covering health and wellness issues a snapshot looking at news and developments for the telemedicine and weight loss market, featuring new player in the market, Integrated Ventures, Inc. (OTCQB: INTV), a portfolio holdings company, focused on e-commerce technology, digital assets and consumer-focused investments.

View Details View Details
Billionaire Bitcoiner slams UK tax system, leaves for Swiss Bitcoin city: Report
Author: Cointelegraph by Brayden Lindrea
United States
Source: Cointelegraph.com News
Sep 30, 2024 12:00

Billionaire Bitcoiner slams UK tax system, leaves for Swiss Bitcoin city: Report

Christian Angermayer claimed the United Kingdoms latest tax proposal for non-doms would be a huge mistake and be a bigger act of national self-harm than Brexit.

View Details View Details
Biotech Stock Pasithea Therapeutics Corp. (NASDAQ: KTTA) Soars on Positive Data from Phase 1 Clinical Trials
United States
Source: Investorideas.com newswire, breaking stock market

Sep 27, 2024 07:05

Biotech Stock Pasithea Therapeutics Corp. (NASDAQ: KTTA) Soars on Positive Data from Phase 1 Clinical Trials

September 26, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Pasithea Therapeutics Corp. (NASDAQ: KTTA), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis type 1 (NF1) and other cancer indications.

View Details View Details
South Korea fines Worldcoin for violating personal protection laws
Author: Cointelegraph by Ezra Reguerra
United States
Source: Cointelegraph.com News
Sep 27, 2024 12:00

South Korea fines Worldcoin for violating personal protection laws

Despite the regulatory hurdles, the projects WLD token surged 35% this week, from $1.60 on Sept. 19 to $2.16 on Sept. 26.

View Details View Details
South Korean foundation to recover funds from defunct crypto exchanges
Author: Cointelegraph by Derek Andersen
United States
Source: Cointelegraph.com News
Sep 26, 2024 12:00

South Korean foundation to recover funds from defunct crypto exchanges

The Digital Asset User Protection Foundation will be set up by the DAXA self-regulatory organization and receive support from financial authorities.

View Details View Details
Wave Life Sciences Ltd. (Nasdaq: WVE) Gains on Clinical Trial News
United States
Source: Investorideas.com newswire, breaking stock market

Sep 25, 2024 07:00

Wave Life Sciences Ltd. (Nasdaq: WVE) Gains on Clinical Trial News

September 24, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health.

View Details View Details
Seelos Therapeutics, Inc. (Nasdaq: SEEL) Soars on update for its SLS-002 (intranasal racemic ketamine) for PTSD
United States
Source: Investorideas.com newswire, breaking stock market

Sep 25, 2024 07:00

Seelos Therapeutics, Inc. (Nasdaq: SEEL) Soars on update for its SLS-002 (intranasal racemic ketamine) for PTSD

September 24, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech technology stocks reports on trading and news for Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases.

View Details View Details
Stocks to Watch Battling the Opioid Epidemic
United States
Source: Investorideas.com newswire, breaking stock market

Sep 21, 2024 07:00

Stocks to Watch Battling the Opioid Epidemic

September 20, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to investing platform covering cannabis stocks releases an industry snapshot looking at the battle against dangerous drugs, including fentanyl, featuring Greenlane Holdings, Inc. (NASDAQ:GNLN), one of the premier global sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products.

View Details View Details
Breaking Medical Technology News: Aethlon (NASDAQ: AEMD) Receives Ethics Committee Approval for Hemopurifier Cancer Trial in India
United States
Source: Investorideas.com newswire, breaking stock market

Sep 20, 2024 07:00

Breaking Medical Technology News: Aethlon (NASDAQ: AEMD) Receives Ethics Committee Approval for Hemopurifier Cancer Trial in India

SAN DIEGO - September 19, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that, on September 9, 2024, the Medanta Institutional Ethics Committee (MIEC) granted full ethics approval for Aethlon's safety, feasibility and dose-finding clinical trial of the Hemopurifier in cancer patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment, such as Keytruda (pembrolizumab) or Opdivo (nivolumab) (AEMD-2022-06 Hemopurifier Study).

View Details View Details
Immunotherapy Clinical Trial News - Stocks to Watch
United States
Source: Investorideas.com newswire, breaking stock market

Sep 20, 2024 07:00

Immunotherapy Clinical Trial News - Stocks to Watch

September 19, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to investing platform, releases the second of a two-part series looking at news and developments for the treatment of cancer and solid tumors focusing on immunotherapy, featuring Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening viral infections.

View Details View Details
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) to Present at Virtual Investor Conferences in September
United States
Source: Investorideas.com newswire, breaking stock market

Sep 18, 2024 07:00

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) to Present at Virtual Investor Conferences in September

SAN DIEGO - September 17, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that management will present at the following virtual investor conferences in September

View Details View Details
Cancer's Solid Tumors Market - the Stocks to Watch
United States
Source: Investorideas.com newswire, breaking stock market

Sep 18, 2024 07:00

Cancer's Solid Tumors Market - the Stocks to Watch

September 17, 2024 (Investorideas.com Newswire) Stocks mentioned-Aethlon Medical, Inc. (Nasdaq: AEMD), Immuneering (Nasdaq: IMRX), Merck (NYSE: MRK), AstraZeneca (Nasdaq: AZN) Roche (OTCQX: RHHBY).

View Details View Details
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier Cancer Trial
United States
Source: Investorideas.com newswire, breaking stock market

Sep 17, 2024 07:00

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier Cancer Trial

SAN DIEGO - September 16, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that the Cancer Clinical Trial Unit at Royal Adelaide Hospital was activated on September 10, 2024 to begin screening and enrolling patients in its safety, feasibility and dose-finding clinical trial of the Hemopurifier in patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment, such as Keytruda (pembrolizumab) or Opdivo (nivolumab) (AEMD-2022-06 Hemopurifier Study).

View Details View Details
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) to Present at the Life Sciences Investor Forum September 19th
United States
Source: Investorideas.com newswire, breaking stock market

Sep 14, 2024 07:00

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) to Present at the Life Sciences Investor Forum September 19th

SAN DIEGO - September 13, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, is pleased to announce that Jim Frakes, interim CEO and CFO and Steve LaRosa, Chief Medical Officer, will present live at the Life Sciences Investor Forum, hosted by VirtualInvestorConferences.com, on September 19th 2024.

View Details View Details
Huge Gains, Huge Volume for Biopharma Stock FSD Pharma Inc (NASDAQ: HUGE) (CSE: HUGE)
United States
Source: Investorideas.com newswire, breaking stock market

Aug 10, 2024 07:00

Huge Gains, Huge Volume for Biopharma Stock FSD Pharma Inc (NASDAQ: HUGE) (CSE: HUGE)

August 9, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas, including biotech stocks reports on trading for FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development.

View Details View Details
Elon Musks X suspends data collection for AI training, EU watchdog says
Author: Cointelegraph by Savannah Fortis
United States
Source: Cointelegraph.com News
Aug 10, 2024 12:00

Elon Musks X suspends data collection for AI training, EU watchdog says

After proceedings in an Irish court, the local Data Protection Commission said X agreed to suspend processing the personal data of EU users to train its AI system.

View Details View Details

Recent Crypto News

May 23, 2025 05:10   
Worldcoin Jumps 10% After World Foundation Raises $135M Through Early Backers
May 23, 2025 05:10   
Michael Saylors Strategy (MSTR) Opens $2.1B ATM Program for Strife Preferred Stock 
May 23, 2025 05:10   
Despite Record Prices, Bitcoin Selling Pressure Craters as Investors Hold Firm, Cryptoquant Reports
May 23, 2025 04:25   
Bitcoin Overtakes Amazon in Total Market Cap, as Supporters Eye even Bigger Targets...
May 23, 2025 04:20   
Ethereum (ETH) Price Prediction 2025, 2026-2030
May 23, 2025 04:20   
Best Cryptos To Invest in for Huge Returns In 2025: Solana, Cardano, Unilabs
May 23, 2025 04:20   
The Rise of AI-Integrated Cryptocurrencies
May 23, 2025 04:20   
Unilabs Finance Hits $800,000 After Referral System Launch, While Litecoin and Cardano Explode
May 23, 2025 04:20   
U.S. Senate Advances GENIUS Act: A Game-Changer for Stablecoin Regulation
May 23, 2025 04:20   
Bitcoin (BTC) Price Prediction 2025, 2026-2030 
Your 1,000 Free WCG Coins Start Here
Your Crypto Gateway

Claim 1,000
Free WCG Coins

World Crypto Global opens the door to digital freedom for everyone.
Manage your free WCG Coins securely—where simplicity meets global accessibility.

Get Start Today How It’s Works

11 bn

FREE CRYPTO COINS

8.9 bn

AVAILABLE FOR RESERVATION

2.1 bn+

ALREADY ALLOCATED

× WCG Coin

🎉 Get 1,000 WCG Coins

No fees. No catch. Your crypto journey starts here.